feed,title,long_url,short_url
ðŸ’°Barrons,"Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isnâ€™t a Problem.",https://barrons.com/articles/novo-nordisk-stock-buy-d0bb8a21?mod=RTA,https://da.gd/6QEdd6
